{"entity":{"type":"insider","cik":"0001277481","url":"/insider/0001277481","json_url":"/insider/0001277481.json","name":"GLICK MARTY","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":2,"n_filings":2,"first":"2004-10-07","last":"2005-02-02","span_basis":"filed_date"},"name_variants":[{"name":"GLICK MARTY","source":"filing","n_filings":2,"first_seen":"2004-10-07","last_seen":"2005-02-02"}],"transactions":[{"id":1435812,"accession":"0001293941-05-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001293941-05-000012","line_url":"/filing/0001293941-05-000012#line-1","is_derivative":false,"issuer_cik":"0001115285","issuer_name":"EYETECH PHARMACEUTICALS INC","issuer_ticker":"EYET","issuer_name_source":null,"issuer_url":"/issuer/0001115285","owner_cik":"0001277481","owner_name":"GLICK MARTY","owner_url":"/insider/0001277481","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6600.0,"shares_display":"6,600","price_per_share":36.15,"price_display":"36.15","price_state":"stated","total_value":238590.0,"total_display":"238,590.00","shares_owned_after":533400.0,"shares_owned_after_display":"533,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-02-01","filed_date":"2005-02-02","scope":"insider"},{"id":497514,"accession":"0001179110-04-019541","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-04-019541","line_url":"/filing/0001179110-04-019541#line-1","is_derivative":false,"issuer_cik":"0001080014","issuer_name":"THERAVANCE INC","issuer_ticker":"THRX","issuer_name_source":null,"issuer_url":"/issuer/0001080014","owner_cik":"0001277481","owner_name":"GLICK MARTY","owner_url":"/insider/0001277481","role":"Officer (Executive VP, Finance and CFO)","officer_title":"Executive VP, Finance and CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":32000.0,"total_display":"32,000.00","shares_owned_after":267805.0,"shares_owned_after_display":"267,805","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-10-05","filed_date":"2004-10-07","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":2,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":2},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001115285","name":"EYETECH PHARMACEUTICALS INC","url":"/issuer/0001115285","role":"Director","n_filings":1,"first_seen":"2005-02-02","last_seen":"2005-02-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001080014","name":"THERAVANCE INC","url":"/issuer/0001080014","role":"Officer (Executive VP, Finance and CFO)","n_filings":1,"first_seen":"2004-10-07","last_seen":"2004-10-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001277481","retrieved_at":"2026-08-21T04:40:02+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}